Marshall Wace North America’s Athenahealth, Inc. ATHN Stock Holding History

Marshall Wace North America’s Portfolio ATHN Stock Details ATHN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-16,164	Closed	-$2.13M	–	2099
2018 Q4	$2.13M	Buy	+16,164	New	+$2.07M	0.02%	416
2018 Q3	–	Sell	-55,336	Closed	-$8.81M	–	1606
2018 Q2	$8.81M	Buy	+55,336	New	+$8.21M	0.05%	360
2017 Q3	–	Sell	-4,834	Closed	-$682K	–	1652
2017 Q2	$682K	Sell	4,834 -21,093	-81%	-$2.63M	0.01%	1032
2017 Q1	$2.93M	Buy	+25,927	New	+$3.02M	0.02%	503

Marshall Wace North America's ATHN Position: Q1 2019 in Review

Marshall Wace North America sold out of Athenahealth, Inc. (ATHN) in Q1 2019, closing a stake of 16,164 shares — an estimated $2.13M sold.

Marshall Wace North America first reported a position in ATHN in Q1 2017 and held it in 4 quarters. The position peaked at $8.81M in Q2 2018. 0 funds tracked by Wall St. Rank hold ATHN as of Q1 2019.

Marshall Wace North America reported no remaining Athenahealth, Inc. position as of Q1 2019 after selling out during the quarter.
Marshall Wace North America sold 16,164 Athenahealth, Inc. shares in Q1 2019, an estimated $2.13M.
Marshall Wace North America first reported a position in Athenahealth, Inc. in Q1 2017 and held it in 4 quarters.
Marshall Wace North America's Athenahealth, Inc. position peaked at $8.81M in Q2 2018.
0 funds tracked by Wall St. Rank held Athenahealth, Inc. as of Q1 2019.

Based on Marshall Wace North America's 13F filing for Q1 2019, filed 14 May 2019.